Therapeutic approaches to bulimia nervosa

Expert Opinion on Therapeutic Patents

Volumn 11, Issue 3, 2001, Pages 463-477

  Spigset, O ^a   Hagg S ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

5 HT (serotonin); Bulimia nervosa; Corticotrophin releasing factor; Neuropeptide Y; Pharmacological therapies

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; BOMBESIN; CHOLECYSTOKININ; COCAINE; CORTICOTROPIN RELEASING FACTOR; DESIPRAMINE; DIURETIC AGENT; DOPAMINE; ENTEROSTATIN; FLUOXETINE; GASTRIN RELEASING PEPTIDE; GLUCAGON; INTERMEDIN; ISOCARBOXAZID; LAXATIVE; LEPTIN; MELANOCORTIN; MONOAMINE OXIDASE INHIBITOR; NALTREXONE; NEUROPEPTIDE Y RECEPTOR; NORADRENALIN; ONDANSETRON; PHENELZINE; PLACEBO; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

APPETITE; BULIMIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EATING DISORDER; FOOD INTAKE; HUMAN; OBESITY; PATENT; PATHOGENESIS; PSYCHOTHERAPY; REVIEW;

EID: 0035118199     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.11.3.463     Document Type: Review

References (44)

1. Psychotherapy for bulimia nervosa and binging (Cochrane Review)
2. Psychosocial and pharmacological treatment of eating disorders: A review of research findings
3. Drug treatment for bulimia nervosa
4. Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder
5. Pharmacology of appetite suppression
6. Research update on serotonin function in bulimia nervosa and anorexia nervosa
7. Promising new approaches to the management of obesity
8. Therapeutic approaches to obesity
9. Serotonin function and selective serotonin reuptake inhibitor treatment in anorexia nervosa and bulimia nervosa
10. Hypothalamic serotonin in control of eating behavior, meal size and body weight
11. 2 receptor agonists on feeding behavior: Possible mechanisms of action
12. 2c receptor activation decreases appetite and body weight in obese subjects
13. Sumatriptan decreases food intake and increases plasma growth hormone in healthy women
14. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa
15. 2A receptor binding in anorexia nervosa and bulimia nervosa
16. Effect of decreasing vagal activity with ondansetron on symptoms of bulimia nervosa: A randomised, double-blind trial
17. Ipsapirone in the treatment of bulimia nervosa: An open pilot study
18. Psychopharmacology of reward and drugs of abuse
19. Destruction of noradrenergic innervation to the paraventricular nucleus: Deficits in food intake, macronutrient selection and compensatory eating after food deprivation
20. Glucocorticoid receptors in PVN: Interactions with NE, NPY and Gal in relation to feeding
21. Neurobiological and psychopharmacological basis in the therapy of bulimia and anorexia
22. CSF monoamine levels in normal-weight bulimia: Evidence for abnormal noradrenergic activity
23. Neurochemical abnormalities of anorexia nervosa and bulimia nervosa
24. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes
25. Treatment of bulimia with bupropion: A multicenter controlled trial
26. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa
27. Leptin, neuropeptide Y and peptide YY in long-term recovered eating disorder patients
28. Neuropeptide Y feeding receptors: Are multiple subtypes involved?
29. The role of CRF2 receptors in corticotropin-releasing factor and urocortin-induces anorexia
30. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands
31. Neurobiology of cholecystokinin
32. Impaired cholecystokinin secretion in bulimia nervosa
33. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
34. CART, a new anorectic peptide
35. 15-Deoxydelta(12,14) prostaglandin J2: A putative endogenous promoter of adipogenesis suppress the ob gene
36. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
37. Opioids and food intake: Disturbed functional neural pathways?
38. Opioid involvement in feeding behavior and the pathogenesis of certain eating disorders
39. CSF beta-endorphin and dynorphin in bulimia nervosa
40. Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa
41. Tissue distribution of the opioid receptor-like (ORL1) receptor
42. The hyperphagic effect of nociceptin/orphanin FQ in rats
43. Orexins: A newly discovered family of hypothalamic regulators of food intake